Mounjaro® (tirzepatide) will be available in the market from the end of May 2025 BANGKOK, THAILAND – Media OutReach Newswire – 27 May 2025 – Zuellig Pharma, a leading healthcare solutions company in Asia, has announced that Mounjaro® (tirzepatide), the...

SINGAPORE – Media OutReach Newswire – 7 January 2025 – Zuellig Pharma, a leading healthcare solutions company in Asia, has announced that it has completed the acquisition of Propan, a market leading brand in the multivitamin-appetite stimulant segment, from ADP...